Dr. George Church is a Professor of Genetics at Harvard Medical School and a co-founder of multiple biotech companies. In this wide-ranging interview, he speaks about his work on de-extinction, his vision of a future without age-related illness, and his AI-powered startups.By adriel saporta, pranav rajpurkar, oishi banerjee, dr. george church, Ashwath Radhachandran, Navami Jain

Karandeep Singh, MD, MMSc, is an Assistant Professor of Learning Health Sciences, Internal Medicine, Urology, and Information at the University of Michigan. He speaks with us about bridging the gap between academia and practice and discusses how the University of Michigan deploys and rigorously evaluates machine learning models in real clinical pra…

Luis Voloch is Co-Founder and Chief Technology Officer at Immunai, which is applying AI to immunology, genomics and drug discovery. He speaks with us about how Immunai is using AI to build a comprehensive, top-of-the-tree view of the immune system.By Pranav Rajpurkar, Adriel Saporta, Oishi Banerjee, Marc Robbins, Ashwath Radhachandran, Navami Jain, Luis Voloch

Dr. Suchi Saria is the Founder and CEO of Bayesian Health, the John C. Malone Associate Professor of computer science, statistics, and health policy, and the Director of the Machine Learning and Healthcare Lab at Johns Hopkins University. She speaks with us on how Bayesian Health uses insights from electronic health records to detect diseases and i…

Dr. Panch is a primary care physician, the Co-Founder of Wellframe, and an instructor at the Harvard T.H. Chan School of Public Health. He speaks with us about Wellframe's work on demystifying complex care regimens, providing personalized support to patients, and understanding social issues affecting healthcare. He also discusses entrepreneurship s…

Dr. Krishna Yeshwant is Managing Partner of GV. In addition to working with GV since its inception, he has earned degrees in computer science, medicine and business, and he practiced at Brigham and Women’s Hospital in Boston, Massachusetts for several years. He speaks with us about different segments of the healthcare market and the role of investo…

Julie Yoo is a General Partner at Andreessen Horowitz where she leads investments in healthcare technology. Prior to joining a16z, Julie was the co-founder, Chief Product Officer, and Board Director at Kyruus, a venture-backed health tech company recognized as a market leader in patient access. She speaks with us about opportunities in digital heal…

Nan Li is Managing Director of Obvious Ventures, leading investments in computational biology visionaries, AI-driven platforms and intelligent robotics companies. He speaks with us on how AI and advances in physical tools are industrializing drug discovery, allowing new medicines to be found at a previously unprecedented pace.…

Joshua A. Gordon, M.D., Ph.D. is the Director of the National Institute of Mental Health (NIMH), the lead federal agency for research on mental disorders. He speaks with us about how AI can be used to provide more accurate psychiatric diagnoses and better target treatments for mental illnesses.By Pranav Rajpurkar, Adriel Saporta, Dr. Joshua Gordon, Oishi Banerjee, Marc Robbins

Dr. Susan Athey is the Economics of Technology Professor at Stanford Graduate School of Business and the Associate Director of the Stanford Institute for Human-Centered Artificial Intelligence. She speaks with us about how AI is reshaping medicine and the economy as a whole, and she discusses the role of businesses, legislators and universities in …

Sherri Rose, Ph.D. is an Associate Professor at Stanford University in the Center for Health Policy and Center for Primary Care and Outcomes Research. She speaks with us about detangling causation from correlation, measuring the effectiveness of different interventions, and influencing real-world health policy. Pranav and Adriel first give an overv…

Varun Ganapathi, Ph.D. is co-founder and CTO at AKASA. He speaks with us about surprise bills and other medical paperwork problems and explores how AI can make healthcare billing less painful for all of us. If you like what you hear, let a friend know, subscribe wherever you get your podcasts, and connect with us on Twitter @AIHealthPodcast.…

Tom Simonite is a senior writer for WIRED covering AI. Previously, he was San Francisco bureau chief at MIT Technology Review, and he wrote and edited technology coverage at New Scientist magazine in London. He speaks with us about his writing process and the challenges of keeping the general public informed about AI and health. If you like what yo…

Dr. Noémie Elhadad is an Associate Professor of Biomedical Informatics, affiliated with Computer Science and the Data Science Institute at Columbia University. She speaks with us about her work on using AI and crowdsourced data to study menstrual health. More broadly, she discusses opportunities and challenges around crowdsourced health information…

Zak Kohane, M.D., Ph.D., is the Chair of the Department of Biomedical Informatics at Harvard Medical School. He speaks with us about sharing medical data and using AI to gain actionable insights from it. Pranav and Adriel first give an overview on the rules and standards that shape medical data sharing today. The interview with Professor Kohane sta…

Vivian S. Lee, M.D., Ph.D., M.B.A. is the President of Health Platforms at Verily Life Sciences and a senior lecturer at Harvard Medical School. She speaks with us about her recent book, The Long Fix: Solving America's Health Care Crisis with Strategies that Work for Everyone, and explores how AI can make the US healthcare system more efficient and…

This is the last episode of Season 1. Join us in the Fall for Season 2, and in the meantime, please take our brief survey! http://bit.ly/theaihealthpodcast Dr. Daphne Koller is CEO and Founder of insitro, a machine-learning enabled drug discovery company. She has been a Stanford CS Professor, co-founder of Coursera and Engageli, one of TIME Magazin…

Bakul Patel is the director of the FDA's Digital Health Center of Excellence. In this interview, he shares his perspective on approving AI systems. He discusses how the FDA is evolving to keep up with the medical AI market, and he addresses key ethical concerns such as equity and access. Pranav and Adriel first give an overview on the FDA's premark…

Harlan Krumholz is a cardiologist and scientist at Yale University and Yale New Haven Hospital. He is the Harold H. Hines, Jr. Professor of Medicine and is the founder and Director of the Yale Center for Outcomes Research and Evaluation (CORE), one of the nation’s most prominent groups working to improve health and health care. In this interview, h…

Mike Coyle is the CEO of iRhythm, and Mark Day is the Executive Vice President of Research & Development of iRhythm, a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine learning capabilities. Together, they speak with us …

Dr. Eric Topol is a cardiologist, a professor, a best-selling author and the founder and director of the Scripps Research Translational Institute. In this wide-ranging conversation, he explains how medical AI can harness new data sources, draw novel connections and restore the human connection between doctor and patient. He also discusses key chall…

Connor Landgraf is the CEO and co-founder of Eko, a cardiopulmonary digital health company. He speaks with us about AI for auscultation, the unique challenges of developing hardware as well as software, and the roller-coaster ride of running a start-up. Pranav and Adriel first give an overview on the history of the stethoscope. The interview with C…

Dr. Emma Pierson is a senior researcher at Microsoft Research and an incoming assistant professor of computer science at Cornell Tech. Her work has been recognized by a Rhodes Scholarship and Forbes 30 Under 30 in Science, and she has written for publications like The New York Times, FiveThirtyEight, The Atlantic, The Washington Post, and Wired. Sh…

Joelle Pineau is co-Managing Director of Facebook AI Research (FAIR), supporting labs across North America and Europe. She is also a faculty member at Mila and an Associate Professor and William Dawson Scholar at the School of Computer Science at McGill University, where she co-directs the Reasoning and Learning Lab. She speaks with us about FAIR's…

Dr. Kiersten Stead is a Managing Partner at DCVC Bio, a venture capital fund supporting companies using deep tech within life science industries. She talks with us about opportunities within biomedical AI, especially around making clinical trials more efficient. Pranav and Adriel first give an overview on digital twin technology for the interview, …

Dr. Charles Cadieu is the co-founder and CEO of Caption Health. Previously, he was an expert in deep learning at MIT and Berkeley and was a founding member of IQ Engines, acquired by Yahoo!. In this interview, he explains how Caption Health is using AI to make it easier for clinicians to capture high-quality ultrasound images. He also discusses bro…

Dr. Adewole "Ade" Adamson is a board-certified dermatologist and assistant professor in the Department of Internal Medicine at Dell Medical School at the University of Texas at Austin. He speaks with us about AI applications in dermatology and addresses challenges around racial bias and overdiagnosis. Pranav and Adriel first talk about the potentia…

Dr. Vijay Pande is a general partner at Andreessen Horowitz and an Adjunct Professor of Bioengineering at Stanford University. As the founding investor of a16z’s Bio Fund, he leads the firm’s investments at the cross section of biology and computer science. He speaks with us about drug discovery and other major opportunities for entrepreneurs in th…

Andrew Ng is Founder of DeepLearning.AI, General Partner at AI Fund, Chairman and Co-Founder of Coursera, and an Adjunct Professor at Stanford University. A pioneer in both machine learning and online education, Dr. Ng now focuses primarily on his entrepreneurial ventures, looking for the best ways to accelerate responsible AI practices in the larg…

Our guests today are Dr. Alastair Denniston and Dr. Xiao Liu. Together they discuss their work on SPIRIT-AI and CONSORT-AI, two pioneering sets of guidelines that help researchers conduct and report AI clinical trials in a safe, transparent manner. Dr. Alastair Denniston is a consultant ophthalmologist, an honorary professor at University Hospitals…

Our guest today is Zavain Dar, a partner at Lux Capital and a founding investor in Anagenex. He speaks about his investments in cutting-edge medical tech companies, especially in the drug discovery space. He also describes common pitfalls faced by medical start-ups and gives advice to aspiring entrepreneurs. Pranav and Adriel first discuss Pfizer-B…

Our guest today is Dr. Lily Peng, a product manager at Google Health. Named to Fortune's 2020 "40 Under 40 - Healthcare" list, she describes her work on automatic disease screening, exploring the challenges of design and deployment. She also discusses her own career path and the role of Big Tech in healthcare. Pranav and Adriel first discuss the ch…

Our guest today is Ian Shakil, Founder, Director, and Chief Strategy Officer of Augmedix. He explains how Augmedix is changing how electronic health records are generated, saving doctors time and improving patient experience. He also tells the story of how he founded Augmedix, and he discusses how his company differentiates itself in a competitive …

Our guest today is LLana James, Faculty of Medicine and PhD candidate at the University of Toronto and the AI, Medicine & Data Justice Post Doctoral Fellow at Queen’s University. She explains how racism has shaped Western medical practice, and she discusses the insidious ways in which old biases resurface in modern medical AI. Pranav and Adriel fir…

Our guest today is Dr. Cynthia Rudin, a professor of computer science, electrical and computer engineering, and statistical science at Duke University. She describes her work on data-driven risk prediction models, which have been validated in real Intensive Care Units and provide a simpler, effective alternative to neural nets. She also discusses t…

Our guest today is Dr. Michael Abramoff, founder and executive Chairman of Digital Diagnostics and a professor at the University of Iowa. He describes how Digital Diagnostics won the first FDA's approval for an autonomous medical AI system. He also gives advice on how to deploy medical AI systems and ensure they are useful, reliable and ethically s…

Our guest today is Dr. Aditya Khosla, co-founder and CTO of PathAI. He discusses PathAI's cutting-edge work on using deep learning for pathology, explaining how AI can more accurately diagnose cancer and personalize medical treatment. He also gives advice from in the trenches on creating and funding successful AI health start-ups. Pranav and Adriel…

Our guest today is Blake Wu, a partner at New Enterprise Associates specializing in healthcare services, healthcare IT, and biopharmaceuticals. He discusses NEA's investments in AI for radiology and medical analytics, plus the challenges of investing in healthcare internationally and the near-term future of medical AI. Before the interview, Pranav …

Our guest today is Dr. Matthew Lungren, Co-Director of the Stanford Center for Artificial Intelligence in Medicine and Imaging and Associate Professor in the Department of Radiology at Stanford University Medical Center. Dr. Lungren discusses the need for AI in radiology, the technical and legal challenges of clinical deployment, and the exciting f…

Our guest today is Annie Lamont, a Co-Founder and Managing Partner of Oak HC/FT, where she focuses on growth equity and early-stage venture opportunities in healthcare. Described by The New York Times as "one of the most successful women ever in the lofty realm of venture capital," Annie talks to us about the evolution of the healthcare market and …

Our guest today is Dr. Abraham Heifets, CEO and Co-Founder of Atomwise, whose research on AI-enhanced drug discovery was featured in the July 2019 Moonshot issue of Newsweek. He discusses Atomwise's pioneering work on the use of deep convolutional neural networks for faster drug discovery, allowing researchers to screen billions of molecules in a m…